ArticleFrontiers in immunology2023

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.

Sarah Bazargan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.